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Gene silencing mediated by small RNAs (such as small interfering RNAs and micro RNAs) is a conserved mech-
anism that affects diverse cellular processes such as heterochromatin formation and mRNA cleavage. Here we
discuss recent studies that further our understanding of RNA silencing in the defense against pathogens as well
as the use of these molecules as antiviral therapeutics.
Flies Dice up RNA Viruses
The innate immune response is the first line of defense against pathogens. RNA inter-
ference (RNAi) has emerged as a component of innate immunity and is involved in the
antiviral response in both plants and animals. Interestingly, plant viruses often pro-
duce inhibitors of the RNAi pathway that subvert the host innate immune response.
In Drosophila, the signaling pathways that contribute to the innate immune response
against viruses (with the exception of the JAK-STAT pathway) have not been eluci-
dated. Wang et al. (2006) and Galiana-Arnoux et al. (2006) now show that RNAi plays
a role in the antiviral response in Drosophila. Both groups examine flies infected with
the flock house virus (FHV), a small virus with an RNA genome. Injection of FHV into
adult flies or fly embryos leads to the accumulation of viral RNA and the production
of viral particles. Interestingly, the viral B2 protein, a known suppressor of RNAi, is
required for this accumulation of viral RNAs. Both groups show that flies lacking com-
ponents of the RNAi machinery, Dicer (Dcr-2) or Argonaute (Ago-2), support replica-
tion of viral RNAs in the absence of B2. Additionally, flies deficient in Dcr-2 or R2D2
(another component of the RNAi machinery) are immunocompromised and more
susceptible to FHV infection than wild-type flies.
Wang et al. show that siRNAs against viral RNA are not detected in Dcr-2-deficient flies, which suggests that Dcr-2
processes the viral dsRNAs into siRNAs. These results implicate the RNAi machinery in the antiviral response in flies
and indicate that suppression of the RNAi machinery by B2 is necessary for the accumulation of viral RNAs. The cur-
rent model is that Dcr-2 cleaves viral dsRNA to make siRNAs that target the viral RNA for destruction. B2 binds to
dsRNA in vitro and blocks cleavage of dsRNA mediated by Dicer. It remains to be elucidated whether this is true
in vivo. Further studies should reveal details of the mechanism of the fly immune response and the viral counter-
attack. Both groups also showed that the RNAi machinery is involved in the response to evolutionarily divergent
RNA viruses such as the Sindbis virus and the cricket paralysis virus, indicating that this may be a general mecha-
nism in insects, including those that act as viral disease vectors, to combat RNA viruses.
X-H. Wang et al. (2006). Science 312, 452–454. Published online March 23, 2006. 10.1126/science.1125694.
D. Galiana-Arnoux et al. (2006). Nat. Immunol. Published online March 23, 2006. 10.1038/ni1335.
miRNA, Auxin Signaling, and Bacterial Resistance
The flagellin protein of bacteria is a trigger for innate immune pathways in animals and plants. In Arabidopsis,
signaling initiated by the recognition of flagellin increases resistance of the plant to infection with bacteria such as
Pseudomonas syringae; however, it is not clear how this occurs. Navarro et al. (2006) now show that RNA silencing
and auxin signaling contribute to this resistance. First, the authors identified cellular transcripts that are repressed
when the seedling is exposed to flagellin. This approach identified several mRNAs including those encoding three
auxin receptors TIR1 (Transport Inhibitor Response 1) and AFB2 and AFB3 (Auxin signaling F box proteins 2 and
3). Exposure to flagellin for 30 min caused a 2- to 3-fold reduction in these transcripts followed by a decrease in
production of the TIR1 protein. The transcripts are downregulated by a conserved miRNA (miR393), indicating
that these auxin receptor genes are transcriptionally repressed. Interestingly, the authors found a 2-fold increase
in miR393 in seedlings exposed to flagellin, and overproduction of this miRNA partially suppressed bacterial growth.
TIR1 is part of an ubiquitin ligase complex that promotes degradation of the Aux/IAA proteins that repress auxin
signaling. Indeed, exposure to flagellin stabilized these proteins and repressed genes that are upregulated in
response to auxin. Remarkably, enhancing auxin signaling by overexpressing AFB1—a functional paralog of TIR1
whose transcript levels are not regulated by miR393—increased the susceptibility to a virulent strain of P. syringae.
These results indicate that auxin increases a plant’s susceptibility to disease; however, the mechanism behind this
phenomenon remains to be elucidated. It will also be interesting to determinewhether there exist bacterial molecules
that are injected into the plant to counter the host response similar to the way in which viruses encode proteins that
block RNA silencing.
L. Navarro et al. (2006). Science 312, 436–439.
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Exploiting Nature’s Way to Combat Viruses
The RNAi antiviral defense mechanism of plant and animal cells could be ex-
ploited in therapeutic strategies to combat human pathogens. Two recent
studies now commandeer RNAi in the laboratory to inactivate two fatal viral
pathogens (Kumar et al., 2006) and to engineer the insect vector of a third
pathogen so that it cannot transmit the virus (Franz et al., 2006). The RNA fla-
viviruses Japanese encephalitis virus (JEV) and West Nile virus (WNV) are
human pathogens that cause fatal encephalitis once they enter the host’s
central nervous system. These two pathogens have the potential to spread
worldwide and are incurable, prompting the need for a fresh look at thera-
peutic options to combat them. Kumar et al. (2006) apply RNAi to prevent
lethal infection of mice with either JEV or WNV. The researchers designed
a short siRNA sequence targeting a highly conserved region of the gene encoding the flavivirus envelope protein.
This siRNA blocked infection of cultured neuronal cells with either JEV or WNV. More importantly, when delivered
to the brains of mice in a cationic lipid formulation up to 6 hr after infection with either JEV or WNV, this siRNA pro-
tected animals from developing encephalitis. Indeed, whereas all untreatedmice died 5 days after flaviviral infection,
more than 80%of animals receiving the siRNA-lipid formulation up to 6 hr postinfection survived. These experiments
hint that RNAi has potential as a therapeutic strategy to combat stubborn human pathogens. However, the challenge
will be to obtain a therapeutic effect without having to administer siRNAs directly into the patient’s brain.
There are other ways that RNAi can be adapted to break the cycle of viral infection. In their RNAi study, Franz et al.
(2006) have focused their attention on the mosquito vector of another fatal human flavivirus, which causes dengue.
One approach to preventing transmission of dengue virus from mosquito to human is to ‘‘dilute’’ the natural popu-
lation of the mosquito vector in dengue-endemic regions with insects genetically engineered so that they cannot
transmit the pathogen. In a first step toward combining this genetic vector control strategy with RNAi, Franz and col-
leagues genetically engineered mosquitoes to express in their midgut epithelial cells inverted-repeat sequences de-
rived from the RNA genome of the dengue type 2 virus. They first demonstrated in cell culture that these inverted
repeat RNAs are triggers for destruction of virus by the cell’s RNAi machinery. Then they examined persistence
of dengue virus in genetically engineered femalemosquitoes that had been allowed to ingest a bloodmeal containing
dengue virus. The midguts of engineered mosquitoes exhibited smaller local infection foci, whereas those of control
insects had much larger infection foci that spread throughout the insect’s body. The researchers confirmed that the
protective effect was due to production of siRNAs in the engineered insect midgut resulting in destruction of the viral
genome. It has been calculated that success of a genetic control strategy for insect vectors of infectious diseaseswill
require the engineered insects to have almost 100% resistance to virus infection. Hence, the next steps will be to
thoroughly optimize the strategy of Franz et al. so that engineered mosquitoes are completely resistant to all four
serotypes of dengue virus.
P. Kumar et al. (2006). PLoS Med. 3, 0505–0514. Published online February 14, 2006. 10.1371/journal.pmed.
0030096.
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RNAi and the Host-Pathogen Molecular Arms Race
Given that the RNAi pathway is an ancient defense against viruses in both plants and animals, it seems likely that
there would be some measure of coevolution between host proteins of the RNAi pathway and viral proteins, but
this has yet to be tested. Obbard et al. (2006) now tackle this issue by comparing gene sequences encoding
RNAi proteins from several different species ofDrosophila. They compared sequences encoding three RNAi proteins
(Dicer2, R2D2, and Argonaute2) involved in innate immunity to sequences encoding paralogous RNAi proteins
(Dicer1, R3D1, Argonaute1) involved in housekeeping functions, such as the regulation of gene expression. For
each protein, they calculated the KA/KS ratio (the ratio of nonsynonymous to synonymous nucleotide substitutions).
Comparison of the ratios between the two sets of RNAi proteins revealed that the rate of evolution for RNAi proteins
involved in innate immunity is much higher than that of their housekeeping counterparts. In fact, Dicer2, R2D2, and
Argonaute2 proteins are among the fastest evolving 3%of all fruit fly proteins. Further investigation based on genetic
polymorphism data revealed that the rapid rate of evolution of these proteins could be attributed to strong positive
selective pressure, probably due to the rapid mutation rate of viral pathogens. Understanding the evolution of RNAi
genes should help to clarify the importance of RNAi in innate immunity and may shed light on the ongoing battle of
coadaptation between host and pathogen.
D.J. Obbard et al. (2006). Curr. Biol. 16, 580–585.
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